Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
myHAE – hereditary angioedema icon

1.0.0 by Takeda Pharmaceuticals


Jul 15, 2022

About myHAE – hereditary angioedema

My Digital HAE Diary

Features:

• HAE attack diary

• Personalised reports

• Treatment planning

• Calendar reminders

• Progress over time

Description:

The myHAE app is an electronic patient diary to support every patient with hereditary angioedema (HAE). The app was designed to help patients and their HCPs gather the information they need to make more informed treatment decisions, together.

Every patient diagnosed with HAE can use the app to track, record and keep detailed information about HAE attacks, their duration and locations, including warning signs and potential triggers. Users can also record information about treatments, take photos of their attacks and generate personalised reports to be shared with their healthcare professionals (sharing tracked data is optional, secure and controlled by the patient). The myHAE app does not replace any advice from healthcare professionals.

What's New in the Latest Version 1.0.0

Last updated on Jul 15, 2022

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request myHAE – hereditary angioedema Update 1.0.0

Requires Android

5.1

Available on

Get myHAE – hereditary angioedema on Google Play

Show More

myHAE – hereditary angioedema Screenshots

Comment Loading...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.